July 01, 2019
TWi Pharmaceuticals must foot part of Supernus Pharmaceuticals' legal bills after relying on a position that was "squarely at odds with the evidence presented" at a patent infringement trial, a New Jersey federal judge has ruled.
August 16, 2017
A New Jersey federal judge ruled Tuesday that Supernus Pharmaceuticals Inc.'s patents related to its anti-epileptic drug are valid and infringed by TWi Pharmaceuticals Inc. and its subsidiary, which had sought permission to market a generic version.